Senti Biosciences (SNTI) Net Margin (2021 - 2023)
Senti Biosciences' quarterly Net Margin came in at 6417.75% in Q3 2023, up 657191.0% year-on-year from N/an in Q3 2022, and up 1091.45% quarter-over-quarter from 647.31% in Q2 2023.
Senti Biosciences has reported Net Margin for 3 years, with the latest figure at 6417.75% in Q3 2023.
- For the quarter ending Q3 2023, Net Margin rose 657191.0% year-over-year to 6417.75%; the trailing twelve-month figure through Jun 2024 stood at 488.17% (up 12430.0% YoY), and the FY2025 full-year result was 308418.18%, changed N/A from the prior year.
- Net Margin for Q3 2023 stood at 6417.75%, up from 647.31% in the prior quarter.
- The five-year high for Net Margin was 6417.75% in Q3 2023, with the low at 1962.45% in Q2 2022.
- Average Net Margin over 3 years is 400.67%, with a median of 566.85% recorded in 2023.
- Year-over-year, Net Margin slumped 80641 bps in 2022 and jumped 657191 bps in 2023.
- Tracing SNTI's Net Margin over 3 years: stood at 486.39% in 2021, then soared by 1020 bps to 4473.82% in 2022, then soared by 43 bps to 6417.75% in 2023.
- The last three Net Margin figures came in at 6417.75% (Q3 2023), 647.31% (Q2 2023), and 378.69% (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.65% |
| 10 | Senti Biosciences Holdings | 22.25 Mn | 22.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 6,417.75% |
| Jun 30, 2023 | -647.31% |
| Mar 31, 2023 | -378.69% |
| Dec 31, 2022 | 4,473.82% |
| Sep 30, 2022 | -154.16% |
| Jun 30, 2022 | -1,962.45% |
| Mar 31, 2022 | -1,064.67% |
| Dec 31, 2021 | -486.39% |
| Sep 30, 2021 | -1,035.18% |
| Jun 30, 2021 | -1,156.04% |